Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
出版年份 2021 全文链接
标题
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma
作者
关键词
-
出版物
EMBO Molecular Medicine
Volume 14, Issue 2, Pages -
出版商
EMBO
发表日期
2021-12-27
DOI
10.15252/emmm.201911814
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance
- (2020) Jose L. Orgaz et al. CANCER CELL
- A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma
- (2020) Christophe A. Girard et al. CANCER RESEARCH
- Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma
- (2020) Jasper Wouters et al. NATURE CELL BIOLOGY
- CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
- (2020) Augustin Luna et al. NUCLEIC ACIDS RESEARCH
- Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
- (2019) Megan M. Tu et al. Science Advances
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway
- (2019) M. Rathore et al. ONCOGENE
- Discoidin domain receptors: A promising target in melanoma
- (2019) Coralie Reger de Moura et al. Pigment Cell & Melanoma Research
- GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism
- (2019) Laura Mondragón et al. CANCER CELL
- Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
- (2019) Florian Rambow et al. GENES & DEVELOPMENT
- Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells
- (2019) S. A. Misek et al. ONCOGENE
- DDR1 autophosphorylation is a result of aggregation into dense clusters
- (2019) David S. Corcoran et al. Scientific Reports
- Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
- (2018) Jennifer Tsoi et al. CANCER CELL
- Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
- (2018) Maya Jeitany et al. EMBO Molecular Medicine
- Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies
- (2018) Robin Didier et al. MOLECULAR CANCER THERAPEUTICS
- Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing
- (2018) Zsofia Miskolczi et al. ONCOGENE
- Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain
- (2018) Whitney R. Grither et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clustering, Spatial Distribution, and Phosphorylation of Discoidin Domain Receptors 1 and 2 in Response to Soluble Collagen I
- (2018) David A. Yeung et al. JOURNAL OF MOLECULAR BIOLOGY
- An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
- (2017) Helen L. Young et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment
- (2017) Riina Kaukonen et al. Nature Protocols
- Fibronectin-guided migration of carcinoma collectives
- (2017) Sandeep Gopal et al. Nature Communications
- Discoidin Domain Receptor 1 Mediates Myosin-Dependent Collagen Contraction
- (2017) Nuno M. Coelho et al. Cell Reports
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib
- (2016) Anne von Mässenhausen et al. INTERNATIONAL JOURNAL OF CANCER
- sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
- (2016) Amanpreet Kaur et al. NATURE
- Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
- (2016) Chiara Ambrogio et al. NATURE MEDICINE
- Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription
- (2016) Riina Kaukonen et al. Nature Communications
- The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis
- (2016) Callie A.S. Corsa et al. Cell Reports
- DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF- B pathway
- (2015) B. Poudel et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
- (2015) Eishu Hirata et al. CANCER CELL
- Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
- (2015) M. H. Kim et al. EMBO JOURNAL
- BRAF Inhibition Generates a Host–Tumor Niche that Mediates Therapeutic Escape
- (2015) Inna V. Fedorenko et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The BRAFV600E inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
- (2015) Molly H. Jenkins et al. MATRIX BIOLOGY
- Cell shape and the microenvironment regulate nuclear translocation of NF- B in breast epithelial and tumor cells
- (2015) J. E. Sero et al. Molecular Systems Biology
- NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
- (2015) G M De Donatis et al. ONCOGENE
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis
- (2015) Mélanie Tichet et al. Nature Communications
- Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
- (2015) Annelien Verfaillie et al. Nature Communications
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Extracellular matrix assembly: a multiscale deconstruction
- (2014) Janna K. Mouw et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
- (2014) Judith Müller et al. Nature Communications
- LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer
- (2014) Jean Albrengues et al. Cell Reports
- Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
- (2013) Hyung-Gu Kim et al. ACS Chemical Biology
- NF- B2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants
- (2013) N. Nadiminty et al. MOLECULAR CANCER THERAPEUTICS
- Discoidin domain receptor tyrosine kinases: new players in cancer progression
- (2012) Rajeshwari R. Valiathan et al. CANCER AND METASTASIS REVIEWS
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Systematic classification of melanoma cells by phenotype-specific gene expression mapping
- (2012) Daniel S. Widmer et al. Pigment Cell & Melanoma Research
- Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
- (2011) R. O. Hynes et al. Cold Spring Harbor Perspectives in Biology
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
- (2008) Elizabeth Day et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now